 | • レポートコード：MRC308GR11572 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の免疫薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の免疫薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 免疫薬の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
免疫薬市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・免疫増強薬、免疫抑制薬
用途別セグメント
・病院、診療所、手術センター、その他
主要な市場プレーヤー
・Antares Pharma, Inc.、UCB、Incyte、GSK、Takeda、3S Bio、Horizon Therapeutics、Bristol-Myers Squibb (BMS、Astellas、Eli Lilly、Mitsubishi Tanabe Pharma、Biogen、Pfizer、Sanofi、Roche、Novartis、Johnson & Johnson (J&J)、Amgen、Abbvi
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、免疫薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な免疫薬メーカーの企業概要、2019年～2022年までの免疫薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な免疫薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別免疫薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの免疫薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での免疫薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および免疫薬の産業チェーンを掲載しています。
・第14、15章では、免疫薬の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 免疫薬の概要
– 種類別分析（2018年vs2022年vs2029年）：免疫増強薬、免疫抑制薬
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所、手術センター、その他
– 世界の免疫薬市場規模・予測
– 世界の免疫薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Antares Pharma, Inc.、UCB、Incyte、GSK、Takeda、3S Bio、Horizon Therapeutics、Bristol-Myers Squibb (BMS、Astellas、Eli Lilly、Mitsubishi Tanabe Pharma、Biogen、Pfizer、Sanofi、Roche、Novartis、Johnson & Johnson (J&J)、Amgen、Abbvi
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：免疫増強薬、免疫抑制薬
・用途別分析2018年-2029年：病院、診療所、手術センター、その他
・免疫薬の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・免疫薬のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・免疫薬のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・免疫薬の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・免疫薬の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Immune Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Immune Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Immune Boosting Drugs
1.3.3 Immunosuppressant Drugs
1.4 Market Analysis by Application
1.4.1 Overview: Global Immune Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Surgery Center
1.4.5 Others
1.5 Global Immune Drugs Market Size & Forecast
1.5.1 Global Immune Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Immune Drugs Sales Quantity (2018-2029)
1.5.3 Global Immune Drugs Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Antares Pharma, Inc.
2.1.1 Antares Pharma, Inc. Details
2.1.2 Antares Pharma, Inc. Major Business
2.1.3 Antares Pharma, Inc. Immune Drugs Product and Services
2.1.4 Antares Pharma, Inc. Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Antares Pharma, Inc. Recent Developments/Updates
2.2 UCB
2.2.1 UCB Details
2.2.2 UCB Major Business
2.2.3 UCB Immune Drugs Product and Services
2.2.4 UCB Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 UCB Recent Developments/Updates
2.3 Incyte
2.3.1 Incyte Details
2.3.2 Incyte Major Business
2.3.3 Incyte Immune Drugs Product and Services
2.3.4 Incyte Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Incyte Recent Developments/Updates
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK Immune Drugs Product and Services
2.4.4 GSK Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 GSK Recent Developments/Updates
2.5 Takeda
2.5.1 Takeda Details
2.5.2 Takeda Major Business
2.5.3 Takeda Immune Drugs Product and Services
2.5.4 Takeda Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Takeda Recent Developments/Updates
2.6 3S Bio
2.6.1 3S Bio Details
2.6.2 3S Bio Major Business
2.6.3 3S Bio Immune Drugs Product and Services
2.6.4 3S Bio Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 3S Bio Recent Developments/Updates
2.7 Horizon Therapeutics
2.7.1 Horizon Therapeutics Details
2.7.2 Horizon Therapeutics Major Business
2.7.3 Horizon Therapeutics Immune Drugs Product and Services
2.7.4 Horizon Therapeutics Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Horizon Therapeutics Recent Developments/Updates
2.8 Bristol-Myers Squibb (BMS
2.8.1 Bristol-Myers Squibb (BMS Details
2.8.2 Bristol-Myers Squibb (BMS Major Business
2.8.3 Bristol-Myers Squibb (BMS Immune Drugs Product and Services
2.8.4 Bristol-Myers Squibb (BMS Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bristol-Myers Squibb (BMS Recent Developments/Updates
2.9 Astellas
2.9.1 Astellas Details
2.9.2 Astellas Major Business
2.9.3 Astellas Immune Drugs Product and Services
2.9.4 Astellas Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Astellas Recent Developments/Updates
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business
2.10.3 Eli Lilly Immune Drugs Product and Services
2.10.4 Eli Lilly Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Eli Lilly Recent Developments/Updates
2.11 Mitsubishi Tanabe Pharma
2.11.1 Mitsubishi Tanabe Pharma Details
2.11.2 Mitsubishi Tanabe Pharma Major Business
2.11.3 Mitsubishi Tanabe Pharma Immune Drugs Product and Services
2.11.4 Mitsubishi Tanabe Pharma Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
2.12 Biogen
2.12.1 Biogen Details
2.12.2 Biogen Major Business
2.12.3 Biogen Immune Drugs Product and Services
2.12.4 Biogen Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Biogen Recent Developments/Updates
2.13 Pfizer
2.13.1 Pfizer Details
2.13.2 Pfizer Major Business
2.13.3 Pfizer Immune Drugs Product and Services
2.13.4 Pfizer Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Pfizer Recent Developments/Updates
2.14 Sanofi
2.14.1 Sanofi Details
2.14.2 Sanofi Major Business
2.14.3 Sanofi Immune Drugs Product and Services
2.14.4 Sanofi Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Sanofi Recent Developments/Updates
2.15 Roche
2.15.1 Roche Details
2.15.2 Roche Major Business
2.15.3 Roche Immune Drugs Product and Services
2.15.4 Roche Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Roche Recent Developments/Updates
2.16 Novartis
2.16.1 Novartis Details
2.16.2 Novartis Major Business
2.16.3 Novartis Immune Drugs Product and Services
2.16.4 Novartis Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Novartis Recent Developments/Updates
2.17 Johnson & Johnson (J&J)
2.17.1 Johnson & Johnson (J&J) Details
2.17.2 Johnson & Johnson (J&J) Major Business
2.17.3 Johnson & Johnson (J&J) Immune Drugs Product and Services
2.17.4 Johnson & Johnson (J&J) Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Johnson & Johnson (J&J) Recent Developments/Updates
2.18 Amgen
2.18.1 Amgen Details
2.18.2 Amgen Major Business
2.18.3 Amgen Immune Drugs Product and Services
2.18.4 Amgen Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Amgen Recent Developments/Updates
2.19 Abbvi
2.19.1 Abbvi Details
2.19.2 Abbvi Major Business
2.19.3 Abbvi Immune Drugs Product and Services
2.19.4 Abbvi Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Abbvi Recent Developments/Updates
3 Competitive Environment: Immune Drugs by Manufacturer
3.1 Global Immune Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Immune Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Immune Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Immune Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Immune Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Immune Drugs Manufacturer Market Share in 2022
3.5 Immune Drugs Market: Overall Company Footprint Analysis
3.5.1 Immune Drugs Market: Region Footprint
3.5.2 Immune Drugs Market: Company Product Type Footprint
3.5.3 Immune Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Immune Drugs Market Size by Region
4.1.1 Global Immune Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Immune Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Immune Drugs Average Price by Region (2018-2029)
4.2 North America Immune Drugs Consumption Value (2018-2029)
4.3 Europe Immune Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Immune Drugs Consumption Value (2018-2029)
4.5 South America Immune Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Immune Drugs Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Immune Drugs Sales Quantity by Type (2018-2029)
5.2 Global Immune Drugs Consumption Value by Type (2018-2029)
5.3 Global Immune Drugs Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Immune Drugs Sales Quantity by Application (2018-2029)
6.2 Global Immune Drugs Consumption Value by Application (2018-2029)
6.3 Global Immune Drugs Average Price by Application (2018-2029)
7 North America
7.1 North America Immune Drugs Sales Quantity by Type (2018-2029)
7.2 North America Immune Drugs Sales Quantity by Application (2018-2029)
7.3 North America Immune Drugs Market Size by Country
7.3.1 North America Immune Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Immune Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Immune Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Immune Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Immune Drugs Market Size by Country
8.3.1 Europe Immune Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Immune Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Immune Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Immune Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Immune Drugs Market Size by Region
9.3.1 Asia-Pacific Immune Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Immune Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Immune Drugs Sales Quantity by Type (2018-2029)
10.2 South America Immune Drugs Sales Quantity by Application (2018-2029)
10.3 South America Immune Drugs Market Size by Country
10.3.1 South America Immune Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Immune Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Immune Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Immune Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Immune Drugs Market Size by Country
11.3.1 Middle East & Africa Immune Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Immune Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Immune Drugs Market Drivers
12.2 Immune Drugs Market Restraints
12.3 Immune Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Immune Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Immune Drugs
13.3 Immune Drugs Production Process
13.4 Immune Drugs Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Immune Drugs Typical Distributors
14.3 Immune Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Immune Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Immune Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Antares Pharma, Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Antares Pharma, Inc. Major Business
Table 5. Antares Pharma, Inc. Immune Drugs Product and Services
Table 6. Antares Pharma, Inc. Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Antares Pharma, Inc. Recent Developments/Updates
Table 8. UCB Basic Information, Manufacturing Base and Competitors
Table 9. UCB Major Business
Table 10. UCB Immune Drugs Product and Services
Table 11. UCB Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. UCB Recent Developments/Updates
Table 13. Incyte Basic Information, Manufacturing Base and Competitors
Table 14. Incyte Major Business
Table 15. Incyte Immune Drugs Product and Services
Table 16. Incyte Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Incyte Recent Developments/Updates
Table 18. GSK Basic Information, Manufacturing Base and Competitors
Table 19. GSK Major Business
Table 20. GSK Immune Drugs Product and Services
Table 21. GSK Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. GSK Recent Developments/Updates
Table 23. Takeda Basic Information, Manufacturing Base and Competitors
Table 24. Takeda Major Business
Table 25. Takeda Immune Drugs Product and Services
Table 26. Takeda Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Takeda Recent Developments/Updates
Table 28. 3S Bio Basic Information, Manufacturing Base and Competitors
Table 29. 3S Bio Major Business
Table 30. 3S Bio Immune Drugs Product and Services
Table 31. 3S Bio Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. 3S Bio Recent Developments/Updates
Table 33. Horizon Therapeutics Basic Information, Manufacturing Base and Competitors
Table 34. Horizon Therapeutics Major Business
Table 35. Horizon Therapeutics Immune Drugs Product and Services
Table 36. Horizon Therapeutics Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Horizon Therapeutics Recent Developments/Updates
Table 38. Bristol-Myers Squibb (BMS Basic Information, Manufacturing Base and Competitors
Table 39. Bristol-Myers Squibb (BMS Major Business
Table 40. Bristol-Myers Squibb (BMS Immune Drugs Product and Services
Table 41. Bristol-Myers Squibb (BMS Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Bristol-Myers Squibb (BMS Recent Developments/Updates
Table 43. Astellas Basic Information, Manufacturing Base and Competitors
Table 44. Astellas Major Business
Table 45. Astellas Immune Drugs Product and Services
Table 46. Astellas Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Astellas Recent Developments/Updates
Table 48. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 49. Eli Lilly Major Business
Table 50. Eli Lilly Immune Drugs Product and Services
Table 51. Eli Lilly Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Eli Lilly Recent Developments/Updates
Table 53. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 54. Mitsubishi Tanabe Pharma Major Business
Table 55. Mitsubishi Tanabe Pharma Immune Drugs Product and Services
Table 56. Mitsubishi Tanabe Pharma Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 58. Biogen Basic Information, Manufacturing Base and Competitors
Table 59. Biogen Major Business
Table 60. Biogen Immune Drugs Product and Services
Table 61. Biogen Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Biogen Recent Developments/Updates
Table 63. Pfizer Basic Information, Manufacturing Base and Competitors
Table 64. Pfizer Major Business
Table 65. Pfizer Immune Drugs Product and Services
Table 66. Pfizer Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Pfizer Recent Developments/Updates
Table 68. Sanofi Basic Information, Manufacturing Base and Competitors
Table 69. Sanofi Major Business
Table 70. Sanofi Immune Drugs Product and Services
Table 71. Sanofi Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Sanofi Recent Developments/Updates
Table 73. Roche Basic Information, Manufacturing Base and Competitors
Table 74. Roche Major Business
Table 75. Roche Immune Drugs Product and Services
Table 76. Roche Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Roche Recent Developments/Updates
Table 78. Novartis Basic Information, Manufacturing Base and Competitors
Table 79. Novartis Major Business
Table 80. Novartis Immune Drugs Product and Services
Table 81. Novartis Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Novartis Recent Developments/Updates
Table 83. Johnson & Johnson (J&J) Basic Information, Manufacturing Base and Competitors
Table 84. Johnson & Johnson (J&J) Major Business
Table 85. Johnson & Johnson (J&J) Immune Drugs Product and Services
Table 86. Johnson & Johnson (J&J) Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Johnson & Johnson (J&J) Recent Developments/Updates
Table 88. Amgen Basic Information, Manufacturing Base and Competitors
Table 89. Amgen Major Business
Table 90. Amgen Immune Drugs Product and Services
Table 91. Amgen Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Amgen Recent Developments/Updates
Table 93. Abbvi Basic Information, Manufacturing Base and Competitors
Table 94. Abbvi Major Business
Table 95. Abbvi Immune Drugs Product and Services
Table 96. Abbvi Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Abbvi Recent Developments/Updates
Table 98. Global Immune Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 99. Global Immune Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 100. Global Immune Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 101. Market Position of Manufacturers in Immune Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 102. Head Office and Immune Drugs Production Site of Key Manufacturer
Table 103. Immune Drugs Market: Company Product Type Footprint
Table 104. Immune Drugs Market: Company Product Application Footprint
Table 105. Immune Drugs New Market Entrants and Barriers to Market Entry
Table 106. Immune Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 107. Global Immune Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 108. Global Immune Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 109. Global Immune Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 110. Global Immune Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 111. Global Immune Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 112. Global Immune Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 113. Global Immune Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Global Immune Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Global Immune Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Global Immune Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Global Immune Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 118. Global Immune Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 119. Global Immune Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Global Immune Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Global Immune Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 122. Global Immune Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 123. Global Immune Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 124. Global Immune Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 125. North America Immune Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 126. North America Immune Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 127. North America Immune Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 128. North America Immune Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 129. North America Immune Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 130. North America Immune Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 131. North America Immune Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 132. North America Immune Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Europe Immune Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 134. Europe Immune Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 135. Europe Immune Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 136. Europe Immune Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 137. Europe Immune Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 138. Europe Immune Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 139. Europe Immune Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 140. Europe Immune Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 141. Asia-Pacific Immune Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 142. Asia-Pacific Immune Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 143. Asia-Pacific Immune Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 144. Asia-Pacific Immune Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 145. Asia-Pacific Immune Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 146. Asia-Pacific Immune Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 147. Asia-Pacific Immune Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 148. Asia-Pacific Immune Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 149. South America Immune Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 150. South America Immune Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 151. South America Immune Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 152. South America Immune Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 153. South America Immune Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 154. South America Immune Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 155. South America Immune Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 156. South America Immune Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 157. Middle East & Africa Immune Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 158. Middle East & Africa Immune Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 159. Middle East & Africa Immune Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 160. Middle East & Africa Immune Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 161. Middle East & Africa Immune Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 162. Middle East & Africa Immune Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 163. Middle East & Africa Immune Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 164. Middle East & Africa Immune Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 165. Immune Drugs Raw Material
Table 166. Key Manufacturers of Immune Drugs Raw Materials
Table 167. Immune Drugs Typical Distributors
Table 168. Immune Drugs Typical Customers
List of Figures
Figure 1. Immune Drugs Picture
Figure 2. Global Immune Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Immune Drugs Consumption Value Market Share by Type in 2022
Figure 4. Immune Boosting Drugs Examples
Figure 5. Immunosuppressant Drugs Examples
Figure 6. Global Immune Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Immune Drugs Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Surgery Center Examples
Figure 11. Others Examples
Figure 12. Global Immune Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Immune Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Immune Drugs Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Immune Drugs Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Immune Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Immune Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Immune Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Immune Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Immune Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Immune Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Immune Drugs Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Immune Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Immune Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Immune Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Immune Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Immune Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Immune Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Immune Drugs Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Immune Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Immune Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Immune Drugs Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Immune Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Immune Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Immune Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Immune Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Immune Drugs Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Immune Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Immune Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Immune Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Immune Drugs Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Immune Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Immune Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Immune Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Immune Drugs Consumption Value Market Share by Region (2018-2029)
Figure 54. China Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Immune Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Immune Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Immune Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Immune Drugs Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Immune Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Immune Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Immune Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Immune Drugs Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Immune Drugs Market Drivers
Figure 75. Immune Drugs Market Restraints
Figure 76. Immune Drugs Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Immune Drugs in 2022
Figure 79. Manufacturing Process Analysis of Immune Drugs
Figure 80. Immune Drugs Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source